JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-7.62 Cr | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr | ₹-0.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of JENBURKT PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-7.62 Cr |
Mar2024 | ₹-7.08 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-5.53 Cr |
Mar2021 | ₹-0.71 Cr |
How is Cash Flow from Financing Activities of JENBURKT PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-7.62 Cr | Negative | |
Mar2024 | ₹-7.08 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-5.53 Cr | Negative | |
Mar2021 | ₹-0.71 Cr | - |
Compare Cash Flow from Financing Activities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹526.1 Cr | -5.3% | -13.7% | 45.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -5.3% |
-13.7% |
45.8% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses